Botulinum antitoxin

Mechanism of action

Botulinum antitoxin solution for injection contains antibodies specific for botulinum neurotoxin types A and B that bind to and neutralize circulating toxin types A and B in the patient.

Pharmacodynamic properties

Formal studies on pharmacodynamics have not been conducted with botulinum antitoxin.

Botulinum antitoxin solution for injection contains IgG antibodies from the immunized donors who contributed to the plasma pool from which the product was derived. The titer of antibodies in the reconstituted product against type A botulinum toxin is at least 15 IU/mL and against type B toxin is at least 4.0 IU/mL. For toxin types A and B, by definition, 1 IU of botulinum antitoxin neutralizes 10,000 intraperitoneal mouse LD50 of botulinum toxin. The titers of antibody against botulinum neurotoxins C, D, and E have not been determined. In the case of infants who may be exposed to botulinum neurotoxin type A or B, this product is expected to provide the relevant antibodies at levels sufficient to neutralize the expected levels of circulating neurotoxin.

Pharmacokinetic properties

Traditional pharmacokinetic studies of botulinum antitoxin have not been performed. However, the following table summarizes the mean serum titer of the anti-A component of botulinum antitoxin following administration.

TimeBotulinum antitoxin Lot 1 Anti-A Titer (mean ± S.D.) Botulinum antitoxin Lot 2 Anti-A Titer (mean ± S.D.)
mIU/mL
Day 1Not done 537.1 ± 213.4
Week 2106.7 ± 44.6 192.2 ± 71.2
Week 490.0 ± 39.2 155.5 ± 56.7
Week 854.9 ± 22.8 96.0 ± 33.2
Week 1226.0 ± 20.5 61.4 ± 32.3
Week 1615.6 ± 10.4 33.0 ± 22.3
Week 207.6 ± 6.6 19.3 ± 14.1

NOTE: 1 IU of anti-type A or anti-type B antibody neutralizes, by definition104, mouse LD50 of botulinum toxin.

The half-life of injected botulinum antitoxin has been shown to be approximately 28 days in infants, which is in agreement with existing data for other immunoglobulin preparations.

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.